Glisovic-Aplenc T, Diorio C, Chukinas JA, et al. CD38 as a pan-hematologic target for chimeric antigen receptor T cells. Blood Adv. 2023;7(16):4418-4430.

doi:10.1182/bloodadvances.2024014719

Page 4424: in Figure 4, the legend between panels A and B showing saline, UTD, CART-38, and daratumumab should be omitted. The corrected Figure 4A-B is shown below:

Figure 4.

View large Download PPT

In vivo activity of CART-38 in AML patient-derived xenograft models.

2024

Glisovic-Aplenc T, Diorio C, Chukinas JA, et al. CD38 as a pan-hematologic target for chimeric antigen receptor T cells. Blood Adv. 2023;7(16):4418-4430.

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology